Clinical Trial Update: Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares top-down therapy with mirikizumab versus standard-of-care azathioprine in newly diagnosed moderate-to-severe ulcerative coliti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Azathioprine (azathioprine)
• Mirikizumab (mirikizumab)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Ulcerative Colitis (UC) | Phase 4 | Status: RECRUITING